Company

ProChimia Surfaces is a privately held company established in 2001 and located in Gdansk area, Poland. Capitalizing on interdisciplinary expertise in the fields of chemistry and  nanotechnology ProChimia delivers state-of-the-art solutions for chemical and biochemical modification of various types of surfaces and materials. Our business has three main components:

(i) We develop and market chemicals for functionalized self-assembled monolayers. Our selection is truly unique, and the compounds we design can be used to modify metals (gold, silver, platinum, copper, etc.), glass, silicon, oxide, or composite surfaces. The thiols, dithiols, dithiolanes, silanes, catechols and coupling reagents we provide are rigorously tested for purity and efficiency. The SAMs (Self-Assembled Monolayers) formed by our chemicals impart the surfaces being coated various properties including bioresistance to non-specific binding of proteins or cells, reactivity toward specific molecules, controlled hyrdophobicity, electrochemical or optical activity, switchability, and more.

(ii) We develop and market a selection of monodisperse metal (Au, Ag, Cu, Pt, Pd) and iron oxide nanoparticles functionalized with various ligands: charged, pH-sensitive, biospecific, etc. (please visit our Nanoparticle Boutique)

(iii) We offer comprehensive custom research services in the fields of chemical- and nano-synthesis. We work closely with our clients to ensure that their scientific needs are fully met.

Our facilities dedicated to nano-composite production and Renewable Energy Research and Development are located at PPNT (Pomeranian Science and Technology Park) in Gdynia.

ProChimia Team

ProChimia a team of experienced and enthusiastic chemists, chemical engineers, biochemists and geneticists. Our scientists are among the best in Central Europe. Every Ph.D. on our team has at least two years of post-doctoral experience in renowned US or EU institutions. Our technicians all boast M.Sc. degrees. We employ only the most accomplished and motivated scientists. Attracting talent from leading academic institutions in Poland is possible because we create an intriguing and stimulating environment for professional and personal growth.

Our Customers

Our products are used by over 2,000 organizations worldwide in fields ranging from chemistry and material science, through molecular diagnostics and biosensors, to micro- and nanotechnology. The list of our clients includes prestigious academic institutions (Harvard, MIT, Stanford, Berkeley, Oxford, ETH, etc.) as well as the leading hi-tech companies (Intel, Fuji, IBM, Qiagene, and more...

Research Projects

We have over a 20-year-long experience in reaserch project management and performnace both privately and externally funded. Our scientists succesfully run the research funded by European Comission under the 7th Framework Programme and Horizon 2020 research and innovation initiatives, including:

• "I-GENE" In-vivo Gene Editing by NanotransducErs (I-GENE H2020-FETOPEN-2018-2019-2020) A Futire Enabling Technology Project proposes a new concept of genome engineering based on nanotransducers (NT), which aims to make safe previously impracticable applications of genome editing and transcriptional regulation by Cas9. The methodology is based on laser-activation of a NT, which triggers a thermo-switchable double strand DNA break or cleavage. The proposed technology implements a concept of multi-input AND gates, where the output (gene editing) is true if multiple inputs are true. In this project ProChimia Surfaces team constructs the nanotansducers capable of performing the safe gene editing in the in vitro set ups. The project proceedings can be followed at 

1. www.prochimia.com
2. I-Gene project webpage and commercial outreach at
3. I-Gene Tools for gene editing

• Waste Value WasteValue is a collabortove research project funded under Norway Grants programme. Its main focus is circular economy and resource recovery by deployment of integrated bioprocessing to recovery processes to formulate a substitute for A-1 jet fuel, natural gas and agriculture fertilizers. Based on our previous experience and IP, ProChimia Surfaces  scientists design and test the optimal set of recovery techniques to isolate the medium length chain carboxylic acids form the fermentation broths.

• "EVO-NANO"  Evolvable platform for programmable nanoparticle-based cancer therapies (EVO-NANO  HORIZON2020-FETOPEN-1-2016-2017) aimed to create an integrated cross-disciplinary platform for the artificial evolution and assessment of nanoparticle-based drug delivery systems. Nanoparticles (NP) are continously being studied in cancer research for their ability to improve diagnosis accuracy and deliver tailored treatments directly to tumours. We have developed and synthesized several combinations of tailored metalic core nanoparticles with dedicated backgrounds and API to teach the AI EVO-NANO algorithms for in silico design of advanced drug delivery candidates. Selected examples of project obtained nanoconstructs are available in our Nanoparticles Boutique

• "Nanofacturing - The Development of Medium and Large-Scale Sustainable Manufacturing Process Platforms for Clinically Compliant Solid Core Nanopharmaceuticals" (NANOFACTURING - HORIZON 2020, 2015-2018). The project is a step ahead for the GMP process development and manufacturing of nanopharmacueticals, aimed at the efficacious and cost effective manufacture of gold core nanoparticles coupled with APIs for clinical use and successful administration in humans both clinical and ultimately commercial scale. ProChimia Team has developed GMP prooven routes of synthesis of glycan mimmicking ligands for Nanofacturing platform. Chosen selection of there product is available in the Thiolated Carbohydrates section of SAMs reagents Catalogue.

• "Sustainable and integrated production of liquid biofuels, bioenergy and green chemicals from glycerol in biorefineries" (GLYFINERY - 7FP, 2008-2012). This international large cooperative project combined our expertise in surface engineering with research on renewable energy source. Our research generated protected IP adressing the purification of bio-fuels and recovery of "green chemicals" produced from biomass;

ProChimia Surfaces is currently running several commercial projects aiming product formulation and production process development.

Running Research Projects

Prochimia Surfaces together with VAXICAN Company is implementing a project entitled: 

"Innovative diagnostic and therapeutic methods in response to the increased threat of arboviruses caused by climate change”

The research is being implemented as part of the European Funds for Pomerania 2021-2027 Program, Priority FEPM.01 European funds for a competitive and smart Pomerania, Measure FEPM.01.01 Research and innovation in enterprises, co-financed by the European Regional Development Fund.

Project Description

As part of the project, ProChimia Surfaces plans to conduct the synthesis and functionalization of gold nanoparticles, enabling cell membrane penetration and the effective binding and inactivation of viral particles. The antiviral features of the designed nanomaterial will be tested on the representatives of arboviruses species including Dengue Virus (DENV), Western Nile Virus (DNV) and Tick-borne encephalitis Virus (TBEV). Studies on their efficacy, stability, bioavailability, and safety (toxicity) are also planned.

Target Audience

The solutions developed within the project will serve a wide range of recipients from the medical, public health, and biotechnology sectors. The end users of the developed technology will be:

• Diagnostic laboratories – public and private centers performing virological and molecular tests;
• Sanitary and epidemiological institutions – requiring tools for rapid and precise identification of arboviruses in environmental and clinical samples;
• Research centers and universities – interested in implementing modern technologies for virus research and inactivation;
• Biotechnology and pharmaceutical companies – developing therapeutic and diagnostic solutions based on nanotechnology;
• Health administration entities – responsible for monitoring epidemiological threats and responding to new outbreaks of infectious diseases.

Project Objective

The objective of the project is to develop an integrated diagnostic platform comprising rapid molecular tests based on nanopore sequencing (ONT) and the development of novel gold nanoparticles with antiviral potential. These technologies will support both the precise detection of arboviruses and their effective neutralization, which is crucial for public health protection.

Project Results

Breaking technological barriers in the diagnosis and therapy of arboviruses and increasing the health security of the residents of Pomerania and the entire country. The project may lead to shorter diagnostic times, efficient preventive actions, a reduction in the spread of viruses, and a lower number of hospitalizations or complications.

The project "Innovative diagnostic and therapeutic methods in response to the increased threat of arboviruses caused by climate change" is consistent with the goals of the Regional Research Agenda "Common Health of Pomerania" and is specifically named in the Resolution of the Board of the Pomeranian Voivodeship No. 1553/51/24.

Implementation period: March 1, 2026 – May 31, 2029

Total project cost: 6,324,998.71 PLN

Total EU Funds contribution: 4,476,616.01 PLN

ProChimia Surfaces Task cost: 1,467,690.39 PLN

ProChimia Surfaces Task EU Funds contribution: 1,174,152.31 PLN

#UEFunds #EuropeanFunds

Research Funding EU Contribution (PL)

ProChimia Surfaces Spółka z ograniczoną odpowiedzialnością z siedzibą w Gdyni, wspólnie z firmą Vaxican Sp. z o.o. realizuje projekt pt.:

„Innowacyjne metody diagnostyczne i terapeutyczne wobec zwiększonego zagrożenia arbowirusami spowodowanego zmianami klimatycznymi” 

realizowany w ramach Programu Fundusze Europejskie dla Pomorza 2021-2027, Priorytetu FEPM.01 Fundusze europejskie dla konkurencyjnego i inteligentnego Pomorza, Działania FEPM.01.01 Badania i innowacje w przedsiębiorstwach, współfinansowanego z Europejskiego Funduszu Rozwoju Regionalnego

Opis projektu:
W ramach projektu opracowane zostaną protokoły izolacji RNA arbowirusów z próbek klinicznych i środowiskowych oraz startery do amplifikacji ich genomów. Opracowany zostanie również zoptymalizowany protokół przygotowania bibliotek NGS dostosowany do szybkiej diagnostyki. Zespół planuje przeprowadzenie syntezy i funkcjonalizacji nanocząstek złota, umożliwiających penetrację błon komórkowych oraz skuteczne wiązanie i inaktywację cząsteczek wirusowych. Przewidziane są badania ich skuteczności, stabilności, biodostępności oraz bezpieczeństwa (toksyczność). Firma planuje rozwój algorytmów bioinformatycznych do analizy danych sekwencyjnych, pozwalających na identyfikację szczepów arbowirusów i wykrywanie nowych wariantów. System zostanie zintegrowany z bazą danych do monitorowania zmian epidemiologicznych. W ramach projektu planowane jest także stworzenie prototypu kompleksowego systemu diagnostycznego, jego wstępna walidacja na próbkach rzeczywistych oraz analiza porównawcza z metodami referencyjnymi.

Grupa docelowa odbiorców projektu:

Rozwiązania opracowywane w ramach projektu będą służyć szerokiemu gronu odbiorców z sektora medycznego, zdrowia publicznego oraz biotechnologii. 

Ostatecznymi użytkownikami opracowanej technologii będą:

• Laboratoria diagnostyczne – publiczne i prywatne ośrodki wykonujące testy wirusologiczne i molekularne;
• Instytucje sanitarno-epidemiologiczne – potrzebujące narzędzi do szybkiej i precyzyjnej identyfikacji arbowirusów w próbkach środowiskowych i klinicznych;
• Ośrodki badawcze i uczelnie – zainteresowane wdrożeniem nowoczesnych technologii badania wirusów i ich inaktywacji;
• Firmy biotechnologiczne i farmaceutyczne – rozwijające rozwiązania terapeutyczne i diagnostyczne oparte na nanotechnologii;
• Podmioty administracji zdrowia – odpowiedzialne za monitorowanie zagrożeń epidemiologicznych i reagowanie na nowe ogniska chorób zakaźnych.

Cel projektu

Celem projektu jest opracowanie zintegrowanej platformy diagnostycznej, obejmującej szybkie testy molekularne oparte na sekwencjonowaniu nanoporowym (ONT) oraz rozwój nowatorskich nanocząstek złota o potencjale przeciwwirusowym. Technologie te będą wspierać zarówno precyzyjne wykrywanie arbowirusów, jak i skuteczne ich unieszkodliwianie, co ma kluczowe znaczenie dla ochrony zdrowia publicznego.

Rezultaty projektu 

Przełamanie barier technologicznych w diagnostyce i terapii arbowirusów i zwiększenie bezpieczeństwa zdrowotnego mieszkańców Pomorza i całego kraju. Projekt może wpynąć na skrócenie czasu diagnostyki, sprawne działania prewencyjne, oraz ograniczenie rozprzestrzeniania się wirusów i mniejszą liczbę hospitalizacji czy powikłań.

Projekt pt. „Innowacyjne metody diagnostyczne i terapeutyczne wobec zwiększonego zagrożenia arbowirusami spowodowanego zmianami klimatycznymi” jest zgodny z celami Regionalnej Agendy Badawczej „Wspólne Zdrowie Pomorza” i imiennie ujęty w Uchwale Zarządu Województwa Pomorskiego nr 1553/51/24.

Termin realizacji: 01.03.2026 r. - 31.05.2029 r.

Całkowity koszt projektu: 6 324 998,71 PLN 

Wkład Funduszy Europejskich: 4 476 616,01 PLN

Koszt zadania ProChimia Surfaces: 1,467,690.39 PLN

Wkład Funduszy Europejskich w zadaniu ProChimia Surfaces: 1,174,152.31 PLN

#FunduszeUE #FunduszeEuropejskie